세계의 코르티코스테로이드 치료 시장 : 유형, 투여 경로, 용도별 예측(2025-2030년)

The Corticosteroids Therapy Market was valued at USD 4.97 billion in 2023, expected to reach USD 5.26 billion in 2024, and is projected to grow at a CAGR of 7.48%, to USD 8.24 billion by 2030.

Corticosteroid therapy involves using synthetic drugs that mimic cortisol-a hormone naturally produced by the adrenal cortex, to reduce inflammation and suppress the immune system. They are critical in treating numerous conditions like arthritis, allergic reactions, asthma, autoimmune disorders, and even certain cancers, underscoring their necessity in medical interventions. These drugs are applied topically, orally, or intravenously and find end-use primarily in healthcare institutions such as hospitals and clinics, pharmaceuticals, and research universities. Market growth factors include the rising prevalence of chronic diseases, increasing awareness about autoimmune diseases, and advancements in drug delivery systems. Furthermore, expansions in healthcare infrastructure in emerging economies present lucrative opportunities. However, challenges such as potential side effects, like increased risk of infection and weakening of bones upon prolonged use, regulatory challenges, and the development of drug resistance may impede market growth. To capitalize on these opportunities, businesses should focus on developing corticosteroids with improved safety profiles and personalized medicine approaches. Innovations in novel drug delivery systems, like inhalers or transdermal patches, could enhance efficacy and minimize side effects. Furthermore, research into non-genomic pathways of corticosteroids could pave the way for innovative therapies. Strategic collaborations with research institutions could enrich product pipelines and accelerate advancements. Monitoring regulatory changes and being agile in compliance can also provide competitive advantages. The corticosteroid therapy market is dynamic, closely tied to fluctuations in healthcare policies and scientific innovations. Companies need to adopt a proactive approach in research and development, focusing on genetically aligned treatments and leveraging digital health technologies to support personalized therapeutic strategies. By effectively navigating the challenges and tapping into the growing demand for tailored healthcare solutions, companies can sustain growth and expand within this evolving market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Corticosteroids Therapy Market

The Corticosteroids Therapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of inflammatory and autoimmune diseases
  • Availability of drug delivery systems with improved convenience and efficacy
  • Therapeutic applications of corticosteroids-therapy in infectious diseases
• Market Restraints
  • Availability of alternative therapies
• Market Opportunities
  • Introduction of novel injectable carrier-based corticosteroid therapy
  • Improvements in single-entity inhaled corticosteroid therapy
• Market Challenges
  • Adverse effects associated with corticosteroids-therapy

Porter's Five Forces: A Strategic Tool for Navigating the Corticosteroids Therapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Corticosteroids Therapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Corticosteroids Therapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Corticosteroids Therapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Corticosteroids Therapy Market

A detailed market share analysis in the Corticosteroids Therapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Corticosteroids Therapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Corticosteroids Therapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Corticosteroids Therapy Market

A strategic analysis of the Corticosteroids Therapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Corticosteroids Therapy Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Allergan PLC by AbbVie Inc., Amgen Inc., AstraZeneca PLC, Biogen Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Cipla Inc., Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, Galderma Group, Gilead Sciences, Inc., GlaxoSmithKline PLC, Lupin Pharmaceuticals, Inc., Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer Inc., Sanofi S.A., SANTHERA PHARMACEUTICALS, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Corticosteroids Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Glucocorticoids and Mineralocorticoids.
• Based on Route of Administration, market is studied across Inhaled, Oral, Systemic, and Topical.
• Based on Application, market is studied across Acute Respiratory Diseases, Endocrinology, Gastroenterology, Rheumatology, and Skin Allergies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of inflammatory and autoimmune diseases
    • 5.1.1.2. Availability of drug delivery systems with improved convenience and efficacy
    • 5.1.1.3. Therapeutic applications of corticosteroids-therapy in infectious diseases
  • 5.1.2. Restraints
    • 5.1.2.1. Availability of alternative therapies
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of novel injectable carrier-based corticosteroid therapy
    • 5.1.3.2. Improvements in single-entity inhaled corticosteroid therapy
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse effects associated with corticosteroids-therapy
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Corticosteroids Therapy Market, by Type

• 6.1. Introduction
• 6.2. Glucocorticoids
• 6.3. Mineralocorticoids

7. Corticosteroids Therapy Market, by Route of Administration

• 7.1. Introduction
• 7.2. Inhaled
• 7.3. Oral
• 7.4. Systemic
• 7.5. Topical

8. Corticosteroids Therapy Market, by Application

• 8.1. Introduction
• 8.2. Acute Respiratory Diseases
• 8.3. Endocrinology
• 8.4. Gastroenterology
• 8.5. Rheumatology
• 8.6. Skin Allergies

9. Americas Corticosteroids Therapy Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Corticosteroids Therapy Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Corticosteroids Therapy Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Allergan PLC by AbbVie Inc.
• 3. Amgen Inc.
• 4. AstraZeneca PLC
• 5. Biogen Inc.
• 6. Boehringer Ingelheim GmbH
• 7. Bristol-Myers Squibb Company
• 8. Cipla Inc.
• 9. Dr. Reddy's Laboratories Ltd.
• 10. Eli Lilly and Company
• 11. Galderma Group
• 12. Gilead Sciences, Inc.
• 13. GlaxoSmithKline PLC
• 14. Lupin Pharmaceuticals, Inc.
• 15. Merck & Co., Inc.
• 16. Mylan N.V.
• 17. Novartis AG
• 18. Pfizer Inc.
• 19. Sanofi S.A.
• 20. SANTHERA PHARMACEUTICALS
• 21. Sun Pharmaceutical Industries Ltd.
• 22. Takeda Pharmaceutical Company Limited
• 23. Teva Pharmaceutical Industries Ltd.